Skip to content

Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial.

Randomized controlled trial · Nutr J · 2024. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 38413933

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial.

Ebrahimpour-Koujan S, Sohrabpour AA, Giovannucci E et al.
Nutr J · 2024

PubMed ID
38413933
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.